Search Results
Results found for "Yang Du"
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
It starts by noticing what grabs your attention, what sparks those quiet “aha” moments during a lecture
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
6️⃣ Long-term viability signals: Does your data hint at durability, repeatability, or translatability
- How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology
These optimizations enabled dual-color labeling strategies, surface-selective imaging, and ultimately What made the collaboration durable wasn’t simply aligned expertise.
- How Collaboration Drives GPCR Discoveries
From GLP-1 and GIP dual agonists to the growing field of GPCR-based delivery systems, collaboration will
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
Here’s how it happens: 1️⃣ Duplicated effort 👉 Two teams think they’re building toward the same milestone
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
The real pivot came during clinical rotations. How do we prevent lean muscle loss during weight loss?
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
In the full lecture, you will learn how to extract affinity even in this dual-behavior scenario: Focus
- How GPCR Collaboration Built an Innovation Engine
The Monash model flipped that logic: Shared infrastructure, not duplicated equipment Centralized core What mattered was how leadership leveraged luck into durable structure — through funding strategies,
- Molecular creativity in drug discovery
. • The Power of Structure : How privileged scaffolds and rational design open the door to dual activity
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Kenakin highlights how hybrid molecules — combining two pharmacophores into one scaffold — enable dual-modality
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
This dual perspective makes Carlsson a trusted partner for industry teams navigating early-stage pipelines
- Innovative Data-Driven Solutions: The pHSense Revolution
However, Trinquet’s team, in collaboration with Professor David Parker from Durham University, cracked
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
peripheral metabolism and systemic energy homeostasis Eiken syndrome with parathyroid hormone resistance due
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
silent advantage of many successful drugs: they bind tightly or covalently , making target coverage durable irreversible mechanisms are designed, not discovered by accident , they become strategic levers: Selective, durable
- Dr. GPCR Updates
Tom Sakmar, Emily Lorenzen, and Ilana Kotliar about creating a multiplex system with DUET-tagged constructs
- New Tools, Smart Signals, and The Kenakin Brief
article GPCR Publication Highlights GLP-1R/GIPR biased agonism enhances metabolic outcomes —with dual
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
Dual control: not just brightness but fluorescence lifetime, with drastic shifts as pH drops. Tag-lite development 🧪 Mid-2010s: Rare-earth scaffold work begins 🔬 2023: pHSense probes optimized for dual It’s the product of layered collaborations—with Durham University chemist David Parker on the probe chemistry
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
In this session, you’ll gain: ✅ A clear map of how drugs interact with enzymes before, during, and after
- The Truth About GPCR Product Launches: Years in the Making
But a pattern emerged: some scaffolds showed dual responsiveness to pH through lifetime and brightness Mini Timeline: The Road to pHSense → Initial lanthanide probe design with Durham University (chemistry ) → Discovery of pH-sensitive dual response (brightness + lifetime) → Application to GPCR models with Revnity’s partnership with Durham (chemistry) and the Institute of Functional Genomics in Montpellier
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
If your team is arguing about “potency vs. effect size vs. duration,” this is your playbook for aligning Working closely with Professor David Parker of Durham University, Trinquet’s group cracked the scaffold
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
A new contributor article from our friends at Celtrays Research outlines how dual-labeled fluorescent Dual-label specificity blocks promiscuous ligand confusion Lanthanide donors + d2 acceptors = high SNR
- Why Opposing Processes Matter for Your Next GPCR Drug
Dobutamine’s dual action on beta and alpha receptors, for example, invites reflex bradycardia that blunts
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
GPCR and global experts at the GPCR Drug Discovery session during Discovery on Target 2025—where groundbreaking
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
Transform Flow Cytometry in GPCR Analysis GPCRs are a tough target in traditional antibody staining due
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
The turning point came during her master’s program in pharmacogenomics.
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
A GPCR program can collapse—not because of bad science, but because brilliant teams are forced into duct
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
Access this week’s key insight ➤ Dr GPCR Podcast – Decoding the Deadly Duo: Xylazine, Fentanyl, and Respiratory
- Why “Displacement” Misleads You: Allosteric Binding Demystified
on G protein coupling (efficacy) γ: G protein’s effect on radioligand binding (efficacy of A) β: Dual
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
This joint effort by both associations is repeated every year, with 2026’s being in Dublin, Ireland. Wendy Young’s talk, during session 3 on day 2, was also incredible. Maria alongside the other panelists during Wednesday's panel discussion. Finally, during Session 9 Prof. Now back in Europe, all she can think about is next year’s date, in Dublin, where she is sure she will
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
During that project we tested its validity as a fluorescent probe for Tag-lite® assays, where we used Figure 2.Assay Principle: TR-FRET assay using CELT-335, a dual (CB1/CB2) fluorescent ligand that serves






























